Incidence, predictors and re-treatment outcomes of recurrent myopic choroidal neo-vascularization
Treatment Patterns for Myopic Choroidal Neovascularization in the United States: Analysis of the IRIS Registry
Ranibizumab in Myopic Choroidal Neovascularization (CNV): The 12-Month Results from the REPAIR Study
RADIANCE: A Randomized Controlled Study of Ranibizumab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia
The Prevalence of Myopic Choroidal Neovascularization (mCNV) in the United States: Analysis of the IRIS® Data Registry and NHANES
Intravitreal Aflibercept Injection in Patients With Myopic Choroidal Neovascularization: The MYRROR Study